Yüklüyor......
Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort
BACKGROUND: Circulating osteoprotegerin (OPG), a member of the receptor activator of nuclear factor kappa-B (RANK) axis, may influence breast cancer risk via its role as the decoy receptor for both the RANK ligand (RANKL) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Circulati...
Kaydedildi:
Yayımlandı: | BMC Med |
---|---|
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
BioMed Central
2017
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5297136/ https://ncbi.nlm.nih.gov/pubmed/28173834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-017-0786-8 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|